| A-scan | A-mode ultrasonography |
| ABCB5 | ATP-binding cassette sub-family B member 5 |
| ADC | Apparent diffusion coefficient |
| AJCC | American Joint committee on cancer |
| AKT | Protein kinase B |
| ALIX | Programmed cell death 6-interacting protein |
| B-scan | B-mode ultrasonography |
| BAP1 | BRCA1-associated protein |
| CD | Cluster of differentiation |
| cfDNA | Cell free DNA |
| CM | Cutaneous melanoma |
| CNV | Copy number variation |
| CT | Computed tomography |
| CTC | Circulating tumor cell |
| ctDNA | Circulating tumor DNA |
| CTDSPL | CTD small phosphatase like |
| CTGF | Connective tissue growth factor |
| CTLA-1 | cytotoxic T-lymphocyte-associated antigen 4 |
| CYSLTR2 | Cysteinyl Leukotriene Receptor 2 |
| DCE-MRI | Dynamic contrast-enhanced magnetic resonance imaging |
| ddPCR | Droplet digital PCR |
| DJ-1 | Parkinson disease protein 7 |
| DNA | Deoxyribonucleic acid |
| dsDNA | Double stranded DNA |
| DW | Diffusion-weighted |
| ECM1 | Extracellular matrix protein 1 |
| EDI | Enhanced depth imaging |
| EIF1AX | Eukaryotic translation initiation factor 1A, X-linked |
| EMT | Epithelial to mesenchymal transition |
| EpCAM | Epithelial cell adhesion molecule |
| EV | Extracellular vesicles |
| FDA | Food and drug administration |
| FDG | Fluorodeoxyglucose |
| FFPE | Formalin-fixed paraffin-embedded |
| FISH | Fluorescence in situ hybridization |
| FNAB | Fine needle aspiration biopsy |
| fSRT | Fractionated stereotactic radiotherapy |
| GNA11 | G-protein α subunit 11 |
| GNAQ | G-protein α subunit Q |
| Gp100 | Glycoprotein 100 |
| HLA | Human leukocyte antigen |
| HOXA11 | Homeobox 11 |
| HTRA1 | Serine proteoase HTRA1 |
| IFN-γ | Interferon gamma |
| IGFBP1 | Insulin-like growth factor-binding protein 7 |
| IL | Interleukin |
| LAMA1 | Laminin subunit alpha-1 |
| LAMP1 | Lysosome-associated membrane glycoprotein 1 |
| LDH | Lactate dehydrogenase |
| MACS | Magnetic activated cell sorting |
| MAGED1 | Melanoma-associated antigen D1 |
| MAGED2 | Melanoma-associated antigen D2 |
| MCAM | Melanoma cell adhesion molecule |
| MCSP | Melanoma-associated chondroitin sulfate proteoglycan |
| MIA | Melanoma inhibitory activity |
| miR | MicroRNA |
| miRNA | MicroRNA |
| MITF | Microphthalmia-associated transcription factor |
| MLANA | Melanoma antigen recognized by T-cells 1 |
| MRI | Magnetic resonance imaging |
| mRNA | Messenger RNA |
| NCAM | Neural cell adhesion molecules |
| NDFIP1 | Nedd4-family interactive protein 1 |
| NHS | National Health Service |
| NRP2 | Neuropilin-2 |
| OCT | Optical coherence tomography |
| OS | Overall survival |
| OXPHOS | Oxidative phosphorylation |
| PAM | Peptidyl-glycine alpha-amidating monooxygenase |
| PBT | proton beam therapy |
| PD-1 | Programmed cell death protein 1 |
| PDHB | Pyruvate dehydrogenase E1 subunit Beta |
| PDT | photodynamic therapy |
| PET/CT | Positron emission tomography/computed tomography |
| PFS | Progression free survival |
| PI3K | Phosphoinositide 3-kinase |
| PLCB4 | Phospholipase C beta 4 |
| PTEN | Phosphatase and Tensin homolog |
| qNPA | Quantitative nuclease protection assay |
| RNA | Ribonucleic acid |
| ROMS | Rotterdam Ocular Melanoma Study group |
| RT-PCR | Reverse transcription polymerase chain reaction |
| RT2-array | Qiagen RT2 miRNA PCR array (brain cancer panel) |
| S-100β | S100 calcium binding protein beta |
| SDHA | Succinate dehydrogenase |
| SERPINE1 | Plasminogen activator inhibitor, type 1 |
| SF3B1 | Splicing factor 3B unit 1 |
| SMART-seq | Switching Mechanism at 5′ end of RNA Template |
| sWGS | Shallow whole genome sequencing |
| THBS2 | Thrombospondin 2 |
| TLDA | Taqman low density array |
| TOP2A | DNA topoisomerase IIa |
| TTT | Transpupillary thermotherapy |
| UK | United Kingdom |
| ULBP2 | UL16-binding protein 2 |
| UM | Uveal melanoma |
| US | Ultrasonography |
| V | Protein V homolog |
| VA | Visual acuity |
| VEGF | Vascular endothelial growth factor |
| VGF | VGF nerve growth factor inducible |
| VH | Vitreous humor |
| γGT | Gamma glutamyl transferase |